Samrat Pharmachem Limited
SAMRATPH
Rank in Stocks
#29146
Samrat Pharmachem Ltd. is a company focused on the production and sale of... Samrat Pharmachem Ltd. is a company focused on the production and sale of various chemical compounds. Its product offerings feature substances like 3-5βDi iodosalicylic acid, aluminium iodide, clioquinol, ethylenediamine dihydroiodide, copper iodine, and lithium iodide. Lalit Damodar Mehta founded the enterprise on June 16, 1992, and it maintains its primary offices in Mumbai, India.
Share Price
$2.77
Last synced: 2026-11-13
Market Cap
$8.56M
Change (1 day)
1.74%
Change (1 year)
-9.90%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Samrat Pharmachem Limited (SAMRATPH)
Category
Basic Materials
EPS for Samrat Pharmachem Limited (SAMRATPH)
EPS as of June 2026 TTM: $-0.08
According to Samrat Pharmachem Limited's latest financial reports, its current EPS (TTM) is $-0.08. At the end of 2025 the company had an EPS of $0.27, an increase over its 2024 EPS of $0.08.
EPS history for Samrat Pharmachem Limited from 2009 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.08 | -128.04% |
| 2025 | $0.27 | 220.62% |
| 2024 | $0.08 | -87.19% |
| 2023 | $0.66 | -10.60% |
| 2022 | $0.73 | 210.73% |
| 2021 | $0.24 | 29.56% |
| 2020 | $0.18 | 154.19% |
| 2019 | $0.07 | -55.22% |
| 2018 | $0.16 | 82.53% |
| 2017 | $0.09 | 491.89% |
| 2016 | $0.01 | -9.20% |
| 2015 | $0.02 | 25.38% |
| 2014 | $0.01 | -45.61% |
| 2013 | $0.02 | -90.09% |
| 2012 | $0.24 | 147.64% |
| 2011 | $0.10 | 10.43% |
| 2010 | $0.09 | -1,342.25% |
| 2009 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.12 | -20,073.58% |
GB
|
|
| $6.44 | -8,604.23% |
FR
|
|
| $7.41 | -9,888.64% |
US
|
|
| $10.98 | -14,604.62% |
US
|
|
| $2.39 | -3,257.20% |
US
|
Questions about Samrat Pharmachem Limited's earnings per share (EPS)
What is Samrat Pharmachem Limited's earnings per share (EPS)?
Samrat Pharmachem Limited's earnings per share (EPS) over the last twelve months is $-0.08, as of Jun 2026.
What was Samrat Pharmachem Limited's earnings per share (EPS) in 2025?
In 2025, Samrat Pharmachem Limited's earnings per share (EPS) was $0.27, 237.50% more than in 2024 ($0.08).
How has Samrat Pharmachem Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Samrat Pharmachem Limited's earnings per share (EPS) went from $0.18 to $0.27, an average growth of 8.45% a year.
How does Samrat Pharmachem Limited's earnings per share (EPS) compare with similar companies?
Samrat Pharmachem Limited's earnings per share (EPS) ($-0.08) is lower than that of all 5 similar companies listed above. The highest among them is Linde plc, with $15.12.